Celsion Corporation (CLSN) Q1 2022 Earnings Conference Call May 16, 2022 11:00 AM ET
Company Participants
Monique Kosse - Investor Relations
Michael Tardugno - Chairman, Chief Executive Officer and President
Jeff Church - Chief Financial Officer
Nicholas Borys - Chief Medical Officer
Khursheed Anwer - Chief Science Officer
Conference Call Participants
Emily Bodnar - H.C. Wainwright
David Bautz - Zacks Small-Cap Research
Operator
Good day, everyone and welcome to Celsion’s First Quarter 2022 Earnings Call. My name is Alan. I will be your operator today. At this time, I’d like to remind everyone that this call is being recorded. I would now like to turn the call over to Ms. Monique Kosse of LifeSci Advisors. Please go ahead, ma’am.
Monique Kosse
Thank you, Alan and good morning everyone. Earlier today, Celsion issued a press release announcing financial results for the first quarter ended March 31, 2022. You may access that release on the company’s website under the Investors tab. With us today are Michael Tardugno, Chairman, CEO and President of Celsion and Jeff Church, Chief Financial Officer. Following management’s prepared remarks, we will open the call for a question-and-answer session.
During this call, management will be making forward-looking statements regarding Celsion’s expectations and projections about future events. Generally, forward-looking statements can be identified by terminologies such as expects, anticipates, believes or other similar expressions. These statements are based on current expectations and are subject to a number of risks and uncertainties, including those set forth in the company’s periodic filings with the Securities and Exchange Commission.
No forward-looking statement can be guaranteed and actual results may differ materially from such statements. In particular, there is significant uncertainty about the duration and impact of the COVID-19 pandemic. This means results could change at any time and the contemplated impact of COVID-19 on Celsion’s operations, financial results and outlook is the best estimate based on the information for today’s discussion. Also, the content of this conference call is accurate only as of the date of the live broadcast today, May 16, 2022. Celsion undertakes no obligation to revise or update comments made during this call, except as required by law.
With that, I would like to now turn the call over to Michael Tardugno, Chairman, CEO and President. Michael?
Michael Tardugno
Thank you, Monique. Good morning, everyone. Joining Jeff and me today are Dr. Nicholas Borys, our Chief Medical Officer and Dr. Khursheed Anwer, our Chief Science Officer. Both of them will participate in the question-and-answer session at the end of the call. Jeff Church, of course, will review our Q1 financial results at the end of my prepared remarks.